骨形態(tài)發(fā)生蛋白2型受體基因在肺動脈高壓發(fā)病機制中的研究進展
發(fā)布時間:2018-01-22 17:51
本文關鍵詞: 肺動脈高壓 肺毛細血管楔壓 平均肺動脈壓 骨形態(tài)發(fā)生蛋白 肺血管阻力 PASMC 壓力異常 漂浮導管 Smad 發(fā)病機制 出處:《中華高血壓雜志》2017年05期 論文類型:期刊論文
【摘要】:正肺動脈高壓(pulmonary arterial hypertension,PAH)是一種罕見的以肺末梢小動脈進行性重構、肺動脈內壓力異常升高為特征的臨床疾病~([1])。PAH診斷標準為靜息狀態(tài)下右心漂浮導管(right-heart catheterization,RHC)測定平均肺動脈壓(mean pressure of pulmonary artery,mPAP)≥25mm Hg(1mm Hg=0.133kPa),肺毛細血管楔壓(pulmonary capillary wedge pressure,PCWP)≤15 mm Hg,肺血管阻力
[Abstract]:Pulmonary arterial hypertensioning (PAH) is a rare progressive remodeling of pulmonary terminal arterioles. Clinical diseases characterized by abnormal elevated pressure in the pulmonary artery (. [1. The diagnostic criteria for PAH were right heart catheterization under resting condition. Mean pressure of pulmonary artery. MPAP 鈮,
本文編號:1455343
本文鏈接:http://sikaile.net/kejilunwen/jiyingongcheng/1455343.html
最近更新
教材專著